Skip to content
buyModerate

Samit Hirawat bought $202k of BMY

EVP,Chief Med.Offr.,Drug Dev. at BRISTOL MYERS SQUIBB CO. 4,250 shares at an average of $47.58, traded Apr 25, 2025, filed Apr 29, 2025.

Conviction score
49
Value
$202k
4,250 shares
Holdings after
83,513
+5% from before
From 52-week low
+3%
low $43.51, close $44.65
From 52-week high
-23%
high $58.20, as of Apr 25, 2025

Score components

  • Role
    Officer
    +15
  • Trade size
    $202k at market
    +12
  • Relative to holdings
    Holdings up 5%
    +3
  • Price context
    3% above the 52-week low; 23% below the 52-week high
    +14
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    2 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BMYOct 9, 2026 · close 59.12
Since filing Apr 29, 2025: +28.9%SPY +42.8% · excess -13.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000014272-25-000093, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 25, 2025POpen-market purchase
Common Stock, $0.10 par value
+4,250$47.58$202k83,513Apr 29, 2025

Related signals

Other insiders at BRISTOL MYERS SQUIBB CO and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
36Weak
BMYsell
BRISTOL MYERS SQUIBB CO
Cristian Massacesi
EVP,Chief Med Offr,Head of Dev
$403k
6,249 shares
-25%
40Moderate
BMYsell
BRISTOL MYERS SQUIBB CO
Benjamin Hickey
President, RayzeBio Org.
$3,702
97 shares
-100%
43Moderate
BMYbuy 2
BRISTOL MYERS SQUIBB CO
Christopher S. Boerner
Chief Executive Officer
$110k
2,000 shares
+2%
33Weak
BMYbuy 2
BRISTOL MYERS SQUIBB CO
Samit Hirawat
EVP,Chief Med.Offr.,Drug Dev.
$100k
1,823 shares
+3%
25Weak
BMYbuy
BRISTOL MYERS SQUIBB CO
Samit Hirawat
EVP,Chief Med.Offr.,Drug Dev.
$100k
1,830 shares
+3%
21Weak
BMYsell
BRISTOL MYERS SQUIBB CO
Phil M Holzer
SVP and Controller
$39k
700 shares
-6%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Samit Hirawat bought $202k of BMY | InsiderTell